Search results for: 'pfth development'

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

The Mobility Technology Opportunity Engine (TOE) covers innovations pertaining to EV Charging, V2X Platforms, LiDAR, and Autonomous Vehicle Development among others.The purpose of the Mobility Technology TOE is to raise awareness of global technology innovations in self-propelled ground-based mobile platforms that are not only technically significa...

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...

This report provides a comprehensive evaluation of emerging technologies, system architectures, and techno-economic dynamics shaping the global Power-to-X landscape. Covering Power-to-Hydrogen, Power-to-Gas, Power-to-Liquid, Power-to-Chemicals, and Power-to-Mobility pathways, the study examines how renewable electricity can be transformed into hydr...

Third-generation photovoltaics represent a fundamental shift in how solar energy is harvested, integrated, and scaled—moving beyond conventional silicon toward tunable, lightweight, and application-specific photovoltaic materials. By advancing perovskite, organic, tandem, and quantum-dot architectures, the industry is unlocking new capabilities in ...

This edition of the IT, Computing and Communication Technology Opportunity Engine captures developments related to Unified AI robotics, Hybrid GPU cloud and MLOps, Production inference stack, Full-stack reinforcement-learning compute, AI Infrastructure, Computer Vision, Software-Defined Applications, Developer Platform & Cloud Application Deploymen...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

The Advanced Manufacturing Technology Opportunity Engine provides profiles of innovations related to Developer-Ready Humanoid for Embodied AI, Fleet-Capable Autonomous Robot for Data Center Concrete Drilling, High-Dexterity Robot End Effector for Enhanced Precision, Hybrid 3D Printing and Milling System for Enhanced Material Casting, AI-Enabled Vis...